An open randomized study of inactivated hepatitis A vaccine administered concomitantly with typhoid fever and yellow fever vaccines

Journal of Travel Medicine

Volumn 9, Issue 2, 2002, Pages 66-70

  Jong, Elaine C ^a   Kaplan, Karen M ^b   Eves, Karen A ^b   Taddeo, Colleen A ^b   Lakkis, Hassan D ^b   Kuter, Barbara J ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; NEUTRALIZING ANTIBODY; TYPHOID VACCINE; YELLOW FEVER VACCINE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; ASTHENIA; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ERYTHEMA; FEMALE; FEVER; HEADACHE; HEPATITIS A; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOGENICITY; MALE; MYALGIA; NAUSEA; NORMAL HUMAN; PAIN; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; TYPHOID FEVER; UPPER RESPIRATORY TRACT INFECTION; YELLOW FEVER;

EID: 0036240102     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2002.21955     Document Type: Article

References (8)

1. Advances in hepatitis A prevention in travellers
2. Epidemiology and prevention of hepatitis A in travellers
3. Risk of hepatitis A in travelers
4. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (AC1P)
5. Vaccination of travelers against hepatitis A and B
6. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk